ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.
Saved in:
| Title: | ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study. |
|---|---|
| Authors: | Stergiopoulou D; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece., Markou A; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece., Nicolo E; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Serafini MS; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Zhang Q; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Zhang Y; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Gerratana L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Davis AA; Division of Oncology, Washington University, St. Louis, MO, USA., Liu H; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Gradishar WJ; Robert H. Lurie Cancer Center of Northwestern University, Feinberg School of Medicine, Chicago, IL, USA., Reduzzi C; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Cristofanilli M; Division of Hematology and Medical Oncology, Weill Cornell Medicine/New York-Presbyterian Hospital, New York, NY, USA., Lianidou E; Analysis of Circulating Tumor Cells, Laboratory of Analytical Chemistry, Department of Chemistry, University of Athens, Athens, Greece. |
| Source: | Molecular oncology [Mol Oncol] 2026 May 27. Date of Electronic Publication: 2026 May 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
